Companies / 858 Therapeutics
858 Therapeutics
San Diego, United States
858 Therapeutics is a clinical-stage biotechnology company developing therapies designed to target tumor dependencies in DNA damage response pathways.
858 Therapeutics, based in San Diego, United States, has 3 investors on file, among them Insight Partners, NEA and Versant Ventures. Its site was last checked 7 Nov 2026: site answers.
SEC Form D filings
3 filingsFiled by 858 Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
3 investors on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital | |
| Portfolio page | Venture capital |
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get 858 Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Insight Partners adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/8five8tx.com/investors
# also
GET /v1/companies/8five8tx.com
GET /v1/companies/8five8tx.com/news